David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDSN
2951
Hudson Technologies
HDSN
$232M
| $2.35M | ﹤0.01% |
409,591
+50,909
| +14% | +$290K |
|
2952
Spyre Therapeutics
SYRE
$9.4B
| $2.35M | ﹤0.01% |
+26,452
| New | +$1.93M |
|
2953
Upwork
UPWK
$1.07B
| $2.35M | ﹤0.01% |
280,751
+179,735
| +178% | +$1.7M |
|
2954
CALL
Arista Networks
ANET
$237B
| $2.34M | ﹤0.01% |
13,800
+8,300
| +151% | +$1.3M |
|
2955
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
| $2.34M | ﹤0.01% |
22,523
+5,116
| +29% | +$517K |
|
2956
Evolus
EOLS
$580M
| $2.34M | ﹤0.01% |
336,901
-222,149
| -40% | -$1.31M |
|
2957
CALL
Enpro
NPO
$6.45B
| $2.34M | ﹤0.01% |
+6,200
| New | +$1.93M |
|
2958
Revolution Medicines
RVMD
$45.3B
| $2.32M | ﹤0.01% |
12,400
-1,009,898
| -99% | -$148M |
|
2959
Treace Medical Concepts
TMCI
$284M
| $2.32M | ﹤0.01% |
583,277
-257,992
| -31% | -$709K |
|
2960
PUT
PENN Entertainment
PENN
$2.45B
| $2.32M | ﹤0.01% |
108,600
-192,600
| -64% | -$3.45M |
|
2961
Standard BioTools
LAB
$255M
| $2.32M | ﹤0.01% |
2,818,026
+2,618,942
| +1,315% | +$2.47M |
|
2962
Sprott Energy Transition Materials ETF
SETM
$631M
| $2.32M | ﹤0.01% |
74,338
+52,025
| +233% | +$1.84M |
|
2963
PUT
Wendy's
WEN
$1.69B
| $2.32M | ﹤0.01% |
+279,300
| New | +$2M |
|
2964
Futu Holdings
FUTU
$16.2B
| $2.31M | ﹤0.01% |
24,695
+23,007
| +1,363% | +$2.95M |
|
2965
Broadstone Net Lease
BNL
$4.34B
| $2.31M | ﹤0.01% |
111,805
-90,424
| -45% | -$1.82M |
|
2966
PUT
Sunrun
RUN
$2.15B
| $2.31M | ﹤0.01% |
172,600
-10,700
| -6% | -$144K |
|
2967
PUT
BridgeBio Pharma
BBIO
$15.8B
| $2.3M | ﹤0.01% |
+30,900
| New | +$2.16M |
|
2968
Amerant Bancorp
AMTB
$1.13B
| $2.3M | ﹤0.01% |
90,139
+11,651
| +15% | +$271K |
|
2969
Pultegroup
PHM
$24.7B
| $2.29M | ﹤0.01% |
16,716
-103,989
| -86% | -$12.6M |
|
2970
Vitamin Cottage Natural Grocers
NGVC
$648M
| $2.29M | ﹤0.01% |
73,905
-17,110
| -19% | -$492K |
|
2971
Velocity Financial
VEL
$728M
| $2.29M | ﹤0.01% |
124,130
+36,396
| +41% | +$662K |
|
2972
Central Garden & Pet Co Class A
CENTA
$2.4B
| $2.28M | ﹤0.01% |
58,897
-22,275
| -27% | -$777K |
|
2973
ARKO Corp
ARKO
$530M
| $2.28M | ﹤0.01% |
283,585
+194,627
| +219% | +$1.36M |
|
2974
CALL
Sweetgreen
SG
$834M
| $2.28M | ﹤0.01% |
258,300
-16,800
| -6% | -$128K |
|
2975
Parsons
PSN
$5.21B
| $2.28M | ﹤0.01% |
43,431
-13,212
| -23% | -$714K |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.